The therapeutic effect of TP on bone destruction in RA has been confirmed in vivo, TP improved bone destruction of TNF-Tg mice by decreasing the levels of pro-inflammatory cytokines, promoting the apoptosis of osteoclast precursors and inhibiting the generation of osteoclast (Wang et al., 2018). Here, TNF is linked to rheumatoid arthritis.